Abnormal measles-mumps-rubella antibodies and CNS
autoimmunity in children with autism.
Singh VK, Lin SX, Newell E, Nelson C.
Department of Biology and Biotechnology Center, Utah State University, Logan,
Utah, USA.
Autoimmunity to the central nervous system (CNS), especially to myelin basic
protein (MBP), may play a causal role in autism, a neurodevelopmental disorder.
Because many autistic children harbor elevated levels of measles antibodies, we
conducted a serological study of measles-mumps-rubella (MMR) and MBP
autoantibodies. Using serum samples of 125 autistic children and 92 control
children, antibodies were assayed by ELISA or immunoblotting methods. ELISA
analysis showed a significant increase in the level of MMR antibodies in
autistic children. Immunoblotting analysis revealed the presence of an unusual
MMR antibody in 75 of 125 (60%) autistic sera but not in control sera. This
antibody specifically detected a protein of 73-75 kD of MMR. This protein band,
as analyzed with monoclonal antibodies, was immunopositive for measles
hemagglutinin (HA) protein but not for measles nucleoprotein and rubella or
mumps viral proteins. Thus the MMR antibody in autistic sera detected measles HA
protein, which is unique to the measles subunit of the vaccine. Furthermore,
over 90% of MMR antibody-positive autistic sera were also positive for MBP
autoantibodies, suggesting a strong association between MMR and CNS autoimmunity
in autism. Stemming from this evidence, we suggest that an inappropriate
antibody response to MMR, specifically the measles component thereof, might be
related to pathogenesis of autism. Copyright 2002 National Science Council, ROC
and S. Karger AG, Basel
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.